Quoin Pharmaceuticals Ltd. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
Quoin Pharmaceuticals Ltd. (QNRX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $208.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2025-03-13
- Quoin Pharmaceuticals Ltd. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was $208.00K, a 24.55% increase from fiscal 2023.
- Quoin Pharmaceuticals Ltd. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $167.00K, a 9.15% increase from fiscal 2022.
- Quoin Pharmaceuticals Ltd. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was $153.00K, a 94.68% decline from fiscal 2021.
- Quoin Pharmaceuticals Ltd. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2021 was $2.88M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|
| 2024-12-31 | $208.00K 10-K · filed 2025-03-13 |
| 2023-12-31 | $167.00K 10-K · filed 2025-03-13 |
| 2022-12-31 | $153.00K 10-K · filed 2024-03-14 |
| 2021-12-31 | $2.88M 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |